Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AVITA Medical (RCEL) Gross Margin (2018 - 2025)

Historic Gross Margin for AVITA Medical (RCEL) over the last 8 years, with Q4 2025 value amounting to 15.56%.

  • AVITA Medical's Gross Margin fell 1553800.0% to 15.56% in Q4 2025 from the same period last year, while for Dec 2025 it was 40.29%, marking a year-over-year decrease of 594900.0%. This contributed to the annual value of 63.93% for FY2025, which is 9693600.0% down from last year.
  • According to the latest figures from Q4 2025, AVITA Medical's Gross Margin is 15.56%, which was down 1553800.0% from 81.32% recorded in Q3 2025.
  • In the past 5 years, AVITA Medical's Gross Margin ranged from a high of 170.93% in Q4 2024 and a low of 15.56% during Q4 2025
  • For the 5-year period, AVITA Medical's Gross Margin averaged around 84.0%, with its median value being 83.68% (2024).
  • Its Gross Margin has fluctuated over the past 5 years, first surged by 835900bps in 2024, then plummeted by -1553800bps in 2025.
  • Quarter analysis of 5 years shows AVITA Medical's Gross Margin stood at 84.5% in 2021, then increased by 1bps to 85.75% in 2022, then increased by 2bps to 87.35% in 2023, then skyrocketed by 96bps to 170.93% in 2024, then crashed by -91bps to 15.56% in 2025.
  • Its Gross Margin stands at 15.56% for Q4 2025, versus 81.32% for Q3 2025 and 81.17% for Q2 2025.